EA199800335A1 - Полиморфные формы стимулятора секреции гормона роста - Google Patents
Полиморфные формы стимулятора секреции гормона ростаInfo
- Publication number
- EA199800335A1 EA199800335A1 EA199800335A EA199800335A EA199800335A1 EA 199800335 A1 EA199800335 A1 EA 199800335A1 EA 199800335 A EA199800335 A EA 199800335A EA 199800335 A EA199800335 A EA 199800335A EA 199800335 A1 EA199800335 A1 EA 199800335A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- polymorphic forms
- growth hormone
- secretion
- methanesulfonylspiro
- phenylmethyloxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Fodder In General (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Hydrogenated Pyridines (AREA)
- Steroid Compounds (AREA)
Abstract
Данное изобретение относится к полиморфным формам соединения N-[1(R)-(1,2-дигидро-1-метансульфонилспиро[3Н-индол-3,4'-пиперидин]-1'-ил)карбонил]-2-(фенилметилокси)этил-2-амино-2-метилпропанамида метансульфоната, которое является стимулятором секреции гормона роста и полезно для введения мясным животным для усиления их роста с помощью этих веществ, что приводит к более эффективному производству мясных пищевых продуктов, а также людям для лечения физиологических и медицинских состояний, характеризующихся недостаточностью секреции гормона роста, а также для лечения медицинских состояний, которые улучшаются за счет анаболических эффектов гормона роста. Рассматриваемые полиморфные формы обладают преимуществами перед другими известными формами N-[1(R)-(1,2-дигидро-1-метансульфонилспиро[3Н-индол-3,4'-пиперидин]-1'-ил)карбонил]-2-(фенилметилокси)этил-2-амино-2-метилпропанамида метансульфоната с точки зрения термодинамической стабильности и удобства для включения в фармацевтические композиции. Настоящее изобретение относится также к способам получения этих полиморфных форм, фармацевтическим композициям, включающим эти полиморфные формы в качестве активных ингредиентов, и использованию полиморфных форм соединения и композиций для лечения определенных нарушений.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US590095P | 1995-10-27 | 1995-10-27 | |
GBGB9603361.8A GB9603361D0 (en) | 1996-02-16 | 1996-02-16 | Polymorphic forms of a growth hormone secretagogue |
PCT/US1996/016955 WO1997015574A1 (en) | 1995-10-27 | 1996-10-23 | Polymorphic forms of a growth hormone secretagogue |
Publications (2)
Publication Number | Publication Date |
---|---|
EA199800335A1 true EA199800335A1 (ru) | 1998-12-24 |
EA000528B1 EA000528B1 (ru) | 1999-10-28 |
Family
ID=26308741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA199800335A EA000528B1 (ru) | 1995-10-27 | 1996-10-23 | Полиморфные формы стимулятора секреции гормона роста |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1019402A1 (ru) |
JP (1) | JP3204266B2 (ru) |
KR (1) | KR19990067098A (ru) |
CN (1) | CN1067687C (ru) |
AU (1) | AU707946B2 (ru) |
BG (1) | BG102476A (ru) |
BR (1) | BR9611229A (ru) |
CA (1) | CA2235371A1 (ru) |
CO (1) | CO4770956A1 (ru) |
CZ (1) | CZ128098A3 (ru) |
EA (1) | EA000528B1 (ru) |
EE (1) | EE9800147A (ru) |
HK (1) | HK1017894A1 (ru) |
HU (1) | HUP9902208A3 (ru) |
IS (1) | IS4721A (ru) |
NO (1) | NO310556B1 (ru) |
NZ (1) | NZ321370A (ru) |
PL (1) | PL327511A1 (ru) |
SK (1) | SK51398A3 (ru) |
TR (1) | TR199800726T2 (ru) |
WO (1) | WO1997015574A1 (ru) |
YU (1) | YU56696A (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6046333A (en) * | 1996-10-25 | 2000-04-04 | Merck & Co., Inc. | Convergent process for the preparation of a growth hormone secretagogue |
US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
WO2017075535A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK282166B6 (sk) * | 1992-12-11 | 2001-11-06 | Merck & Co., Inc. | Spiropiperidínové deriváty, spôsob ich výroby a farmaceutický prostriedok s ich obsahom |
-
1996
- 1996-10-23 HU HU9902208A patent/HUP9902208A3/hu unknown
- 1996-10-23 SK SK513-98A patent/SK51398A3/sk unknown
- 1996-10-23 PL PL96327511A patent/PL327511A1/xx unknown
- 1996-10-23 CZ CZ981280A patent/CZ128098A3/cs unknown
- 1996-10-23 EP EP96936869A patent/EP1019402A1/en not_active Withdrawn
- 1996-10-23 JP JP51673797A patent/JP3204266B2/ja not_active Expired - Lifetime
- 1996-10-23 EA EA199800335A patent/EA000528B1/ru not_active IP Right Cessation
- 1996-10-23 EE EE9800147A patent/EE9800147A/xx unknown
- 1996-10-23 WO PCT/US1996/016955 patent/WO1997015574A1/en not_active Application Discontinuation
- 1996-10-23 BR BR9611229A patent/BR9611229A/pt not_active IP Right Cessation
- 1996-10-23 TR TR1998/00726T patent/TR199800726T2/xx unknown
- 1996-10-23 AU AU74686/96A patent/AU707946B2/en not_active Expired
- 1996-10-23 CA CA002235371A patent/CA2235371A1/en not_active Abandoned
- 1996-10-23 CN CN96199328A patent/CN1067687C/zh not_active Expired - Lifetime
- 1996-10-23 NZ NZ321370A patent/NZ321370A/xx not_active IP Right Cessation
- 1996-10-23 KR KR1019980703038A patent/KR19990067098A/ko not_active Application Discontinuation
- 1996-10-25 YU YU56696A patent/YU56696A/sh unknown
- 1996-10-25 CO CO96056663A patent/CO4770956A1/es unknown
-
1998
- 1998-04-21 IS IS4721A patent/IS4721A/is unknown
- 1998-04-24 NO NO19981867A patent/NO310556B1/no not_active IP Right Cessation
- 1998-05-21 BG BG102476A patent/BG102476A/xx unknown
-
1999
- 1999-07-12 HK HK99102961A patent/HK1017894A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CO4770956A1 (es) | 1999-04-30 |
AU7468696A (en) | 1997-05-15 |
KR19990067098A (ko) | 1999-08-16 |
HUP9902208A2 (hu) | 1999-10-28 |
EA000528B1 (ru) | 1999-10-28 |
CN1067687C (zh) | 2001-06-27 |
NO981867L (no) | 1998-06-29 |
YU56696A (sh) | 1999-09-27 |
BG102476A (en) | 1999-04-30 |
WO1997015574A1 (en) | 1997-05-01 |
HK1017894A1 (en) | 1999-12-03 |
CA2235371A1 (en) | 1997-05-01 |
JP3204266B2 (ja) | 2001-09-04 |
BR9611229A (pt) | 1999-05-25 |
HUP9902208A3 (en) | 2001-05-28 |
NZ321370A (en) | 1999-11-29 |
SK51398A3 (en) | 1998-12-02 |
NO310556B1 (no) | 2001-07-23 |
AU707946B2 (en) | 1999-07-22 |
TR199800726T2 (xx) | 1998-08-21 |
JPH10512295A (ja) | 1998-11-24 |
IS4721A (is) | 1998-04-21 |
PL327511A1 (en) | 1998-12-21 |
EE9800147A (et) | 1998-12-15 |
MX9803351A (es) | 1998-09-30 |
NO981867D0 (no) | 1998-04-24 |
CN1205703A (zh) | 1999-01-20 |
CZ128098A3 (cs) | 1998-09-16 |
EP1019402A1 (en) | 2000-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mori et al. | Controlled locomotion in the mesencephalic cat: distribution of facilitatory and inhibitory regions within pontine tegmentum | |
RU95107663A (ru) | Бензо-конденсированные лактамы, ускоряющие высвобождение соматотропного гормона, способы их получения, способы лечения, композиции | |
DE69634609D1 (de) | Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu-opioidanagonisten und eines kappa - 2- opioidanagonisten | |
RU95113347A (ru) | Спиропиперидины и их гомологи, способ получения, способ повышения уровней эндогенного гормона роста, способ лечения остеопороза, фармацевтическая композиция | |
ES2055911T3 (es) | Compuesto farmaceutico adelgazante. | |
DE69230112D1 (de) | Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin | |
EA200001247A1 (ru) | N-связанные сульфонамиды n-гетероциклических карбоновых кислот или изостеры карбоновых кислот | |
NO157145C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive n-glykosylerte karboksylsyreamidderivater. | |
EA199800337A1 (ru) | Способ получения гормона роста, усиливающего секрецию | |
ATE409028T1 (de) | Arzneien zur behandlung von nervenerkrankungen | |
ATE265851T1 (de) | Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden | |
EA199800335A1 (ru) | Полиморфные формы стимулятора секреции гормона роста | |
NZ209743A (en) | Use of growth hormone to enhance ruminant mammary development | |
Thompson et al. | Chronic effects of nicotine on rat gastric secretion | |
Poschel et al. | Arousal deficit shown in aged rat's quantitative EEG and ameliorative action of pramiracetam compared to piracetam | |
Lao et al. | Electroacupuncture reduces morphine-induced emesis in ferrets: a pilot study | |
Hanna et al. | The role of nitric oxide in the control of protein secretion in the parotid gland of anaesthetized sheep | |
RU2005140739A (ru) | Применение альфа-кетоглутаровой кислоты для лечения недостаточности питания или состояния с высоким уровнем глюкозы в плазме | |
ATE184489T1 (de) | Behandlung fehlender milchabsonderung beim menschen | |
Sˇusˇić et al. | The effects of delta-sleep-inducing peptide (DSIP) on wakefulness and sleep patterns in the cat | |
HUT57040A (en) | Process for producing pharmaceutical compositions comprising 2-brackets open 4-(4-chlorophenyl)-cyclohexyl brackets closed-3-hydroxy-1,4-naphthoquinone suitable for treating toxoplasmosis | |
RU2372082C2 (ru) | Способ оздоровления организма при заболеваниях сердечно-сосудистой и нервной системы | |
HUT60431A (en) | Process for producing pharmaceutical compositions comprising naphthoquinone derivative and suitable for treating cryptosporidiosis | |
Decima | Effects of blood calcium changes on spinal reflex activity | |
SU1044286A1 (ru) | Способ лечени невралгии тройничного нерва |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
PD4A | Registration of transfer of a eurasian patent in accordance with the succession in title | ||
PD4A | Registration of transfer of a eurasian patent in accordance with the succession in title | ||
MK4A | Patent expired |
Designated state(s): RU |